Jobs / United States / Sanofi US Services INC
Medical Excellence Lead, Hong Kong and Taiwan
Sanofi US Services INC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Sanofi US Services INC paid sponsored hires in similar roles4 certified filings for “Senior Scientist” (Medical Scientists, Except Epidemiologists) in MA: $107k–$122k, median $115k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Sanofi US Services INC
The US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Sanofi US Services INC →
About the role
About the job We are an innovative global healthcare company with a focus on immunology that extends to innovation in diabetes and transplant medicine. Across different countries, our talented teams are determined to deliver a best-in-class customer experience using the best of digital, artificial intelligence and personal know-how. With a focus on immunology that extends to innovation in diabetes and transplant medicines, we pursue progress to make a real impact on millions of patients around the world The Medical Excellence Lead for Hong Kong Taiwan is a strategic leadership role responsible for driving medical operation excellence, enhancing patient solutions, and establishing best-in-class medical practices across TWHK markets. This position serves as the operational backbone of medical affairs, ensuring seamless execution of medical strategies while fostering innovation and continuous improvement in patient-centered healthcare delivery. Main responsibilities: Medical Operations Excellence • Establish operational frameworks for medical activities including medical information, scientific communications, advisory boards, and investigator-initiated studies to drive consistent excellence across therapeutic areas • Lead cross-functional medical project management, implementing governance structures that ensure strategic prioritization, resource optimization, and timely delivery of medical initiatives • Drive standardization of medical processes and procedures across Taiwan and Hong Kong, establishing best practices that enhance efficiency, compliance, and quality outcomes • Oversee medical budget planning and resource allocation, ensuring optimal utilization of resources to maximize medical impact Medical Excellence & Scientific Leadership • Champion medical excellence initiatives that elevate scientific rigor, evidence generation, and thought leadership positioning across the TWHK medical organization • Establish frameworks for local evidence generation including real-world evidence studies, investigator-sponsored research, and publication strategies that support medical objectives Lead medical capability building programs to enhance team competencies in scientific communication, medical writing, data analysis, and stakeholder engagement • Drive medical innovation and digital transformation initiatives that modernize medical operations, enhance HCP engagement, and improve patient outcomes • Implement quality assurance systems for medical activities, ensuring compliance with regulatory requirements, industry codes, and internal standards Patient Solutions & Access • Manage, monitor and track the quality of patient support and assistance programs • Support the establishment of medical education frameworks that enhance healthcare provider knowledge and improve patient care standards • Develop and oversee comprehensive patient support program (PSP) strategy addressing patient access barriers, affordability concerns, and treatment adherence across therapeutic areas • Support patient assistance program (PAP) operations, ensuring eligible patients receive financial or co-payment support to access Sanofi therapies • Establish patient support frameworks including patient education programs, treatment support services, and patient advocacy initiatives • Collaborate with market access and commercial teams to develop integrated patient support strategies that enhance patient outcomes • Ensure regulatory compliance of all patient support programs in accordance with Taiwan and Hong Kong regulations, industry codes, and Sanofi policies • Drive patient insights generation to inform program design, identify unmet support needs,